OC90
Basic information
Region (hg38): 8:132024216-132059382
Previous symbols: [ "PLA2L" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the OC90 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 31 | 34 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 31 | 3 | 0 |
Variants in OC90
This is a list of pathogenic ClinVar variants found in the OC90 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-132024497-G-A | not specified | Uncertain significance (Dec 30, 2023) | ||
8-132024515-C-T | not specified | Uncertain significance (Mar 29, 2024) | ||
8-132024527-C-T | not specified | Likely benign (Nov 10, 2022) | ||
8-132024599-C-A | not specified | Uncertain significance (Jun 10, 2024) | ||
8-132024626-T-G | not specified | Uncertain significance (May 08, 2023) | ||
8-132024632-C-G | not specified | Uncertain significance (Dec 16, 2022) | ||
8-132024633-T-C | not specified | Likely benign (Aug 02, 2021) | ||
8-132024644-G-T | not specified | Uncertain significance (Nov 09, 2021) | ||
8-132024650-G-A | not specified | Uncertain significance (Sep 12, 2023) | ||
8-132024670-T-A | not specified | Uncertain significance (Nov 21, 2023) | ||
8-132024687-G-A | not specified | Uncertain significance (May 03, 2024) | ||
8-132024705-C-A | not specified | Uncertain significance (Sep 12, 2023) | ||
8-132024748-C-G | not specified | Uncertain significance (Oct 26, 2021) | ||
8-132029105-G-A | not specified | Uncertain significance (Dec 03, 2021) | ||
8-132029132-C-G | not specified | Uncertain significance (Feb 03, 2022) | ||
8-132029137-C-G | not specified | Uncertain significance (Mar 29, 2022) | ||
8-132031903-C-T | not specified | Uncertain significance (Sep 26, 2023) | ||
8-132031906-C-T | not specified | Uncertain significance (Jul 09, 2021) | ||
8-132031954-G-A | not specified | Uncertain significance (Mar 12, 2024) | ||
8-132031960-G-A | not specified | Uncertain significance (May 30, 2023) | ||
8-132032019-C-G | not specified | Uncertain significance (Oct 10, 2023) | ||
8-132033064-A-T | not specified | Uncertain significance (Jul 12, 2023) | ||
8-132033102-T-A | not specified | Uncertain significance (Apr 07, 2022) | ||
8-132033153-T-C | not specified | Uncertain significance (Dec 21, 2021) | ||
8-132034826-G-A | not specified | Uncertain significance (Apr 11, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
OC90 | protein_coding | protein_coding | ENST00000254627 | 13 | 35161 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.68e-12 | 0.114 | 124510 | 1 | 136 | 124647 | 0.000550 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.01 | 301 | 256 | 1.18 | 0.0000128 | 3088 |
Missense in Polyphen | 107 | 86.391 | 1.2386 | 1122 | ||
Synonymous | -2.15 | 125 | 98.0 | 1.28 | 0.00000522 | 930 |
Loss of Function | 0.573 | 19 | 21.9 | 0.868 | 0.00000108 | 264 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000426 | 0.000426 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000112 | 0.000111 |
Finnish | 0.000513 | 0.000511 |
European (Non-Finnish) | 0.000878 | 0.000867 |
Middle Eastern | 0.000112 | 0.000111 |
South Asian | 0.000450 | 0.000392 |
Other | 0.000335 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Major protein of the otoconia, a calcium carbonate structure in the saccule and utricle of the ear. Together with OTOL1, acts as a scaffold for otoconia biomineralization: sequesters calcium and forms interconnecting fibrils between otoconia that are incorporated into the calcium crystal structure. Together with OTOL1, modulates calcite crystal morphology and growth kinetics. It is unlikely that this protein has phospholipase A2 activity. {ECO:0000250|UniProtKB:Q9Z0L3}.;
- Pathway
- phospholipases
(Consensus)
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- loftool
- 0.373
- rvis_EVS
- 0.45
- rvis_percentile_EVS
- 77.98
Haploinsufficiency Scores
- pHI
- 0.0490
- hipred
- N
- hipred_score
- 0.146
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0223
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Oc90
- Phenotype
- hearing/vestibular/ear phenotype; normal phenotype;
Zebrafish Information Network
- Gene name
- oc90
- Affected structure
- otolith
- Phenotype tag
- abnormal
- Phenotype quality
- aplastic
Gene ontology
- Biological process
- phospholipid metabolic process;biological_process;lipid catabolic process;otolith mineralization;otolith development;arachidonic acid secretion
- Cellular component
- cellular_component;extracellular matrix
- Molecular function
- molecular_function;phospholipase A2 activity;structural molecule activity;calcium ion binding